NCT06696573 Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
| NCT ID | NCT06696573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Le Thi Kieu Trang |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-12-13 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-12-13 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to assess the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) for prophylactic pain relief compared to on-demand pain relief during medical abortion for pregnancies between 13 and 22 weeks at Hung Vuong Hospital in Ho Chi Minh City. The main questions it aims to answer are: 1. Does prophylactic use of NSAIDs reduce pain compared to on-demand use during medical abortion? 2. What are the potential adverse effects of NSAIDs in this context? Researchers will compare a group receiving prophylactic NSAIDs to a control group receiving on-demand pain relief to determine if the prophylactic approach leads to improved pain management outcomes. Participants will: * Be given NSAIDs either as a preventative measure or upon the onset of pain. * Be monitored for pain levels using validated pain scales, any side effects, and outcomes of the abortion procedure.
Eligibility Criteria
Inclusion Criteria: * Pregnant women aged 18 years or older. * No mental illness. * Gestational age between 13 and 22 weeks (based on the last menstrual period with a regular menstrual cycle and accurate recall of the last menstrual period, or based on a first-trimester ultrasound) with an indication of stillbirth, fetal malformation requiring termination, or voluntary abortion with counseling and understanding of the abortion procedure. * Willing to participate in the study. * Capable of reading and signing the informed consent form. * Able to provide personal information independently. Exclusion Criteria: * Medical conditions contraindicating medical abortion: bleeding disorders, anticoagulant use, moderate to severe anemia. * Cardiovascular conditions: heart failure, mitral valve stenosis, embolism, uncontrolled hypertension. * Other medical conditions: renal failure, adrenal gland disorders, severe asthma, liver and biliary diseases, glaucoma. * Active pelvic inflammatory disease or acute genital infections. * Previous uterine surgery. * Placenta previa or central placenta previa. * Uterine malformations. * History of allergy to NSAIDs, Mifepristone, or Misoprostol. * Unwillingness to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06696573 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06696573 currently recruiting?
Yes, NCT06696573 is actively recruiting participants. Contact the research team at lethikieutrang912@gmail.com for enrollment information.
Where is the NCT06696573 trial being conducted?
This trial is being conducted at Ho Chi Minh City, Vietnam.
Who is sponsoring the NCT06696573 clinical trial?
NCT06696573 is sponsored by Le Thi Kieu Trang. The trial plans to enroll 180 participants.